Stephen T. Zarrilli

Board Director

Director

Virtus Investment Partners, Inc.Safeguard Scientifics Inc Globus Medical Inc

Insider activity · 24 months0 buys1 saleCumulative net flow

Nov 24 · 0 buys · 0 salesDec 24 · 0 buys · 0 salesJan 25 · 0 buys · 0 salesFeb 25 · 0 buys · 0 salesMar 25 · 0 buys · 0 salesApr 25 · 0 buys · 0 salesMay 25 · 0 buys · 0 salesJun 25 · 0 buys · 0 salesJul 25 · 0 buys · 0 salesAug 25 · 0 buys · 0 salesSept 25 · 0 buys · 0 salesOct 25 · 0 buys · 0 salesNov 25 · 0 buys · 0 salesDec 25 · 0 buys · 0 salesJan 26 · 0 buys · 0 salesFeb 26 · 0 buys · 0 salesMar 26 · 0 buys · 0 salesApr 26 · 0 buys · 0 salesMay 26 · 0 buys · 0 salesJun 26 · 0 buys · 0 salesJul 26 · 0 buys · 0 salesAug 26 · 0 buys · 1 saleSept 26 · 0 buys · 0 salesOct 26 · 0 buys · 0 sales

Total declarations

Companies

▲ Purchases (0 ops.)

—

▼ Sales (3 ops.)

€2.8M

Latest filing published 19 Aug 2026 for Globus Medical INC, €1.1M. Read the official filing

Filing timeline

BuySale

Stephen T. Zarrilli

Insider track record

Disclosed buys

Disclosed sells

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

Stephen T. Zarrilli: trading record in brief

Stephen T. Zarrilli is a declared insider at 3 companies (board member); the most frequent names are Virtus Investment Partners, Inc., Globus Medical Inc and Safeguard Scientifics Inc. Between 31 December 2015 and 18 August 2026, the trades on record add up to 9 filings.

The open-market record consists of 3 sales worth €2.8M, with no purchase. Outside the open market, there are 4 share grants and 2 option exercises. In 2026 alone, the filings show no purchases and 1 sale.

On 19 August 2026 came the latest disclosure, an option exercise for €1.1M in Globus Medical Inc. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.